Oxford Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-109,575
| Closed | -$8.52M | – | 576 |
|
|
2019
Q4 | $8.52M | Buy |
109,575
+92,904
| +557% | +$7.22M | 0.24% | 92 |
|
|
2019
Q3 | $1.22M | Buy |
+16,671
| New | +$1.22M | 0.03% | 824 |
|
|
2019
Q2 | – | Sell |
-13,695
| Closed | -$873K | – | 1780 |
|
|
2019
Q1 | $873K | Buy |
+13,695
| New | +$873K | 0.02% | 987 |
|
|
2018
Q3 | – | Sell |
-10,575
| Closed | -$514K | – | 1748 |
|
|
2018
Q2 | $514K | Sell |
10,575
-73,122
| -87% | -$3.55M | 0.01% | 1331 |
|
|
2018
Q1 | $3.89M | Sell |
83,697
-25,485
| -23% | -$1.19M | 0.08% | 257 |
|
|
2017
Q4 | $4.17M | Buy |
+109,182
| New | +$4.17M | 0.09% | 273 |
|
|
2017
Q3 | – | Sell |
-17,952
| Closed | -$708K | – | 1577 |
|
|
2017
Q2 | $708K | Buy |
+17,952
| New | +$708K | 0.01% | 1007 |
|
|
2016
Q4 | – | Sell |
-58,500
| Closed | -$2.35M | – | 800 |
|
|
2016
Q3 | $2.35M | Buy |
+58,500
| New | +$2.35M | 0.07% | 371 |
|
|
2015
Q3 | – | Sell |
-410,430
| Closed | -$9.74M | – | 651 |
|
|
2015
Q2 | $9.74M | Sell |
410,430
-231,060
| -36% | -$5.49M | 0.26% | 77 |
|
|
2015
Q1 | $15.2M | Buy |
641,490
+41,748
| +7% | +$991K | 0.39% | 39 |
|
|
2014
Q4 | $13M | Sell |
599,742
-88,500
| -13% | -$1.92M | 0.29% | 56 |
|
|
2014
Q3 | $11.7M | Buy |
+688,242
| New | +$11.7M | 0.27% | 72 |
|
|
2014
Q2 | – | Sell |
-166,566
| Closed | -$2.06M | – | 719 |
|
|
2014
Q1 | $2.06M | Buy |
+166,566
| New | +$2.06M | 0.06% | 356 |
|